Effect of early measles vaccination (AIK-C strain) for preterm infants

Pediatrics International

Volumn 55, Issue 2, 2013, Pages 163-168

  Ichikawa, Tomonori ^a   Tsuji, Atsutoshi ^b   Fujino, Motoko ^c   Kusano, Ryousuke ^a   Sugiyama, Ryusuke ^a   Oomori, Sayu ^a   Mori, Kazuhiro ^a   Maeyama, Katsuhiro ^a   Nakayama, Tetsuo ^d  

^a Saitama Municipal Hospital   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c SAISEIKAI CENTRAL HOSPITAL   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

AIK C; measles vaccination; neutralization test antibody; preterm infants

Indexed keywords

IMMUNOGLOBULIN; MEASLES ANTIBODY; MEASLES VACCINE; NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BIRTH WEIGHT; BLOOD TRANSFUSION; CONVULSION; DRUG ERUPTION; DRUG FEVER; ERYTHEMA; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MEDICAL HISTORY; PREMATURITY; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; JAPAN; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RETROSPECTIVE STUDIES; TIME FACTORS; VACCINATION;

EID: 84876551160     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12064     Document Type: Article

References (22)

1. WHO. Expanded programme on immunization (EPI): Safety of high titre measles vaccines. Wkly Epidemiol. Rec. 1992; 67: 357-361.
2. WHO. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. Wkly Epidemiol. Rec. 2002; 77: 224-228.
3. WHO. Progress in global measles control and mortality reduction, 2000-2007. Wkly Epidemiol. Rec. 2008; 83: 441-448.
4. WHO. Measles vaccines. WHO position paper. Wkly Epidemiol. Rec. 2009; 84: 349-360.
5. CDC. Increased transmission and outbreaks of measles-European region, 2011. MMWR Morb. Mortal. Wkly Rep. 2011; 60: 1605-1610.
6. CDC. Progress toward measles elimination: Japan, 1999-2008. MMWR Morb. Mortal. Wkly Rep. 2008; 57: 1049-1052.
7. Nakayama T, Zhou J, Fujino M,. Current status of measles in Japan. J. Infect. Chemother. 2003; 9: 1-7.
8. National Institutes for Infectious Diseases. Measles in Okinawa. IASR 2001; 22: 224-225. (in Japanese).
9. Nagai M, Ji Y-X, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007-2008. J. Med. Virol. 2009; 81: 1094-1101.
10. Leineweber B, Grote V, Schaad UB,. Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr. Infect. Dis. J. 2004; 2004 (23): 361-363.
11. Tsuji A, Nakayama T,. Seroepidemiological study on prevalence of measles antibodies in Urawa City. Keio J. Med. 1998; 47: 209-211.
12. Fujino M, Yoshida N, Kimura K, et al. Development of a new neutralization test for measles virus. J. Virol. Methods 2007; 142: 15-20.
13. Albrecht P, Ennis FA, Saltzman EJ, Krugman S,. Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure. J. Pediatr. 1977; 91: 715-718.
14. D'Angio CT, Boohene PA, Mowrer A,. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants. Pediatrics 2007; 119: e574-579.
15. Gunes T, Koklu E, Ozturk MA, Akcakus M,. Antimeasles antibodies in preterm infants during early infancy in Turkey. Ann. Trop. Paediatr. 2007; 27: 31-37.
16. Ohsaki M, Tsutsumi H, Takeuchi R,. Placental transfer of measles antibodies: Effect of gestational age and maternal vaccination status. Scand. J. Infect. Dis. 1999; 31: 17-19.
17. Ozbek S, Vural M, Tastan Y, Kahraman I,. Passive immunity of premature infants against measles during early infancy. Acta Paediatr. 1999; 88: 1254-1257.
18. Johnson CE, Nalin DR, Chui LW, Whitwell J,. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Pediatrics 1994; 93: 939-494.
19. Bolotovski VM, Grabowsky M, Clements CJ, et al. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine. Int. J. Epidemiol. 1994; 23: 1069-1077.
20. Nkrumah FK, Osei-kwasi M, Dunyo SK, Koram KA, Afari EA,. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: A randomized controlled trial in Ghana. Bull. World Health Organ. 1998; 76: 353-359.
21. Tidjani O, Gruntsky B, Guérin N, et al. Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet 1989; 9: 1357-1361.
22. Pabst HF, Spady DW, Carson MM, Krezolek MP,. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine 1999; 17 (15-16): 1910-1918.